Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine peritoneal dialysis solution for nocturnal APD in ESRD
2007-000606-75Phase 2Completed
- Sponsor
- Iperboreal Pharma
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levocarnitine in end-stage kidney disease (ESKD), sponsored by Iperboreal Pharma. Primary endpoints: Weekly Kt/V, Weekly plasmatic creatinine clearance and 5 more. Started Sep 2007; status: completed.
02
Drugs
levocarnitine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2007-000606-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000606-75.